Edgewise Therapeutics, Inc. (EWTX) Balance Sheet Quarterly

Edgewise Therapeutics, Inc.

EWTX (NASDAQ)

(%)

Financials
Edgewise Therapeutics, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 (Q3) 09-30	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30	2024 (Q1) 03-31
Report Filing:	2025-11-06	2025-08-07	2025-05-08	2025-03-03	2024-11-07	2024-08-08	1234
Total Current Assets	573.9	603.3	443.2	475.5	499.4	519.4	1234
Cash and Short Term Investments	563.3	594	436.4	470.2	492.5	511.8	1234
Cash & Equivalents	46	43.4	49.92	41.67	44.81	43.48	1234
Short Term Investments	517.3	550.6	386.5	428.5	447.7	468.3	1234
Receivables	0	0	0	0	0	0	1234
Inventory	0	0	0	0	0	0	1234
Other Current Assets	10.56	9.26	6.79	5.31	6.9	7.69	1234
Total Assets	583.5	613.3	454.4	486.8	511.3	531.6	1234
Total Non-Current Assets	9.57	10.08	11.21	11.33	11.85	12.21	1234
Property, Plant and Equipment	9.57	10.08	10.52	11.07	11.58	11.94	1234
Goodwill and Intangible Assets	0	0	0	0	0	0	1234
Goodwill	0	0	0	0	0	0	1234
Intangible Assets	0	0	0	0	0	0	1234
Long Term Investments	0	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	0	0	0.695	0.262	0.262	0.262	1234
Total Current Liabilities	21.65	20.9	21.11	23.86	18.96	17.18	1234
Accounts Payable	6.16	8.32	8.79	5.58	5.65	6.8	1234
Notes Payable/Short Term Debt	1.01	1	1	0.996	0.992	0.988	1234
Tax Payables	0	0	0	0	0	0	1234
Deferred Revenue	0	0	0	0	0	-0.988	1234
Other Current Liabilities	14.48	11.57	11.32	17.29	12.32	10.38	1234
Total Liabilities	24.82	24.26	24.67	27.6	22.41	21.17	1234
Total Non-Current Liabilities	3.17	3.37	3.56	3.74	3.45	4	1234
Total Long Term Debt	3.17	3.37	3.56	3.74	3.45	4	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0	0	0	0	0	1234
Capital Lease Obligations	0	4.37	4.56	4.74	4.44	4.99	1234
Other Long Term Liabilities	0	-4.37	-4.56	-4.74	-4.44	-4.99	1234
Total Equity	558.6	589.1	429.7	459.2	488.9	510.5	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	558.6	589.1	429.7	459.2	488.9	510.5	1234
Retained Earnings	-496.2	-455.5	-419.4	-378.6	-338.9	-304.8	1234
Accumulated Other Earnings	0.701	0.204	0.401	0.42	1.05	-1.05	1234
Common Stock	0.01	0.01	0.009	0.009	0.009	0.009	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	1,054	1,044	848.7	837.4	826.7	816.3	1234
Total Liabilities & Total Equity	583.5	613.3	454.4	486.8	511.3	531.6	1234
Total Liabilities & Shareholders' Equity	583.5	613.3	454.4	486.8	511.3	531.6	1234
Total Investments	517.3	550.6	386.5	428.5	447.7	468.3	1234
Total Debt	4.18	4.37	4.56	4.74	4.44	4.99	1234
Net Debt	-41.82	-39.03	-45.36	-36.93	-40.37	-38.5	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Edgewise Therapeutics, Inc. Balance Sheet Statement Quarterly